Let's take a close look at four active penny stocks that have garnered attention with their recent activity and news. These low-priced stocks present an interesting possibility for investors looking to capitalize on potential opportunities.

Let's examine their recent performance as well as their noteworthy developments, where valuable insights into their market position, and potential insights into their future outlook can be found.

It's time to jump into the world of active penny stocks, uncovering the latest activity and news that sets them apart in this dynamic market segment.

Epazz, Inc. (OTC:EPAZ) is a company specializing in drone technology, blockchain mobile apps, and cloud-based business software solutions that has been making significant advancements in the technology industry throughout 2023.

For example, their remarkable spinoff company, ZenaDrone Inc., has been garnering significant attention with its intelligent UAV technology that incorporates machine learning software in addition to AI. While initially developed with the intention of revolutionizing the hemp farming sector, ZenaDrone has since evolved into a versatile solution for military uses, industrial surveillance, agricultural inspection and monitoring, and more.

In particular, ZenaDrone's cutting-edge drone technology has attracted the interest of the U.S. military. The U.S. Military has highlighted their ZenaDrone 1000 flagship drone for sensitive cargo delivery applications, including blood transportation. The military's recognition of EPAZ's drone solution has validated the company's technological capabilities and established it as a trusted provider of mission-critical solutions.

Impressively, the U.S. Air Force has invited ZenaDrone to conduct tests under battlefield conditions at an overseas base, showcasing the military's confidence in their drone technology. With advanced payloads, EPAZ's drones can significantly contribute to military logistics, surveillance, and search and rescue missions, enhancing safety and efficiency in remote or hazardous areas.

Shaun Passley, Ph.D., CEO of Epazz, expressed excitement about ZenaDrone's increasing recognition in multiple military branches. He emphasized the Air Force's enthusiasm for pushing the boundaries of testing and acknowledged the critical feedback they anticipate as they transition to mass production operations.

Turning our attention to Epazz's most recent update, the company has made a significant move by forming Galaxy Batteries Inc. as a subsidiary to house its intellectual property for battery technology.

Throughout the development of the ZenaDrone 1000 and its various updates, Epazz has been actively developing special battery technologies for high-powered devices and aircraft. EPAZ is now in the process of filing patents to protect their innovations.

According to the company, the formation of Galaxy Batteries positions it as a potential independent company in the future.

Epazz's CEO, Shaun Passley, Ph.D., highlighted the evolving nature of their projects, stating, "When we first started the drone project back in 2019, we could not have foreseen all of the technologies we needed to create in order to meet our requirements. As the project has taken shape, new opportunities have risen. We're evaluating how best to monetize the varied technologies we have developed and how best to provide value to the company."

The company recently launched galaxybatteries.com as the official website for its battery technology subsidiary, underscoring its commitment to this venture. With Epazz's expertise in drone technology combined with their advancements in battery technologies, Galaxy Batteries holds immense potential for further growth and innovation.

These recent developments within the ZenaDrone and Galaxy Batteries divisions could be a sign of Epazz's strength and versatility in the technology sector. With its focus on innovation, strategic partnerships, and the pursuit of emerging market opportunities, Epazz continues to push forward its position in the industry.

GBT Technologies Inc. (OTC: GBTC) is a company in the development stage that focuses on emerging technologies such as Internet of Things (IoT), Artificial Intelligence (AI), and Enabled Mobile Technology Platforms, with the aim of enhancing integrated circuit (IC) performance. The company has brought together a team of highly skilled professionals with deep expertise in technology and is actively building an intellectual property portfolio that includes numerous patents.

Earlier this week, the company announced that GBT received a notice of allowance for its nonprovisional patent application for the integrated circuit (IC) geometrical design rule automatic correction system and method, known internally as Omega.

This patent protects GBT's technology for automatically correcting geometrical design rule violations within an IC layout, eliminating the need for manual intervention. By leveraging artificial intelligence neural network algorithms, GBT aims to perform IC layout corrections within minutes, significantly reducing design time. The technology analyzes the layout, identifies violations, and formulates strategies for rectification, improving the designs' quality and electrical characteristics. This innovative approach holds the potential to enhance chip performance, achieve higher silicon yield, and accelerate the development of advanced semiconductors.

GBT plans to continue its research and development efforts in this domain, introducing further advancements in the field in the coming years.

Enzolytics, Inc. (OTC: ENZC) is a drug development biotech company specializing in proprietary proteins and monoclonal antibodies for infectious diseases. Their flagship compound, ITV-1, has demonstrated effectiveness in treating HIV/AIDS and modulating the immune system.

In recent developments for ENZC, the company's wholly owned subsidiary, Virogentics, recently received a crucial analysis report from the Bulgarian Academy of Sciences. The report provides detailed information on protein concentration, native enzyme concentration, peptide analysis, and amino acid sequence for Module 3. This milestone achievement brings ENZC closer to fulfilling the manufacturing conditions required for the production of validation orders, anticipated to commence in mid-September of this year.

With the report in hand, Virogentics is now gearing up to embark on clinical trials in Germany. These trials mark a crucial step forward in validating the efficacy and safety of ENZC's immunotherapy treatment, ITV-1.

The impact of the ITV-1 immunotherapy treatment on the volunteers will be closely monitored and assessed throughout the 17-week cycle. This data will provide valuable insights into the effectiveness and potential benefits of the treatment. With a focus on addressing the needs of the African population, where the largest population of AIDS victims resides, ENZC is determined to make a tangible difference in the fight against HIV/AIDS.

The progress made toward distributing their patented immunotherapy treatment to HIV patients in Africa is a significant milestone for ENZC and demonstrates their commitment to tackling this global health challenge.

In addition to these advancements, ENZC is actively engaged in negotiations with SAGA regarding a potential business combination. The company's increased market value in recent weeks has prompted further discussions to ensure a mutually beneficial outcome for both parties. Harry Zhabilov, Chief Scientific Officer of VIRO and ENZC, expressed his optimism, stating, "The continued development of the ITV-1 family of products and advances we are making toward distribution of our patented immunotherapy treatment to HIV patients in Africa is more than I could have hoped."

These recent developments position ENZC as an up-and-coming player in the field of infectious disease therapeutics, showcasing their commitment to innovation, scientific rigor, and addressing critical healthcare needs.

Asia Broadband Inc. (OTC: AABB) is a resource company that specializes in the production, supply, and sale of precious and base metals. With a primary focus on Asian markets, AABB leverages its specific geographic expertise, extensive industry contacts, and valuable experience to facilitate an innovative distribution process.

In addition to its core business in the metals industry, AABB has expanded into the digital asset sector. As part of its digital assets business segment, the company launched the AABBG token, a gold-backed cryptocurrency. The AABBG token is supported by AABB's mine-to-token concept, in which the company's gold reserves back the cryptocurrency's value. This provides stability and trust, positioning the token as a reliable standard of exchange within the cryptocurrency market.

AABB recently announced plans for a platform change in its digital assets business segment, specifically for the AABBG token. The company aims to lower transaction costs, increase processing speeds, enhance liquidity, and improve user satisfaction. The platform change is expected to be completed by June 30, with further details to follow.

With record-breaking sales of the AABBG token generating $3.9 million in revenue during the first quarter of 2023, AABB reported a healthy gross profit of $4.6 million. The company also achieved significant milestones in its mining operations, with continued gold production and plans for expansion in the second half of the year.

AABB is actively working on enhancing its digital assets division, including improvements to the AABBG token, AABB Exchange, and PayAABB. The implementation of these improvements will take place in the upcoming months with assistance from partnerships with industry leaders in the cryptocurrency, blockchain, and cybersecurity sectors.

Disclaimers:CapitalGainsReport (CGR) is not operated by a licensed broker, a dealer, or a registered investment adviser. This content is for informational purposes only and is not intended to be investment advice. The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investors investment may be lost or impaired due to the speculative nature of the companies profiled. CapitalGainsReport (CGR) is owned by RazorPitch Inc. and has been retained by Epazz Inc. to assist in the production and distribution of content. 'CGR' is responsible for the production and distribution of this content. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. This content is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice. Nothing contained in this article constitutes a solicitation, recommendation, endorsement, or offer by CapitalGainsReport/RazorPitch or any third party service provider to buy or sell any securities or other financial instruments. All content in this article is information of a general nature and does not address the circumstances of any particular individual or entity. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. CGR/RazorPitch is not a fiduciary by virtue of any persons use of or access to this content.

CONTACT: CapitalGainsReport

Mark McKelvie

Editor

Markrmckelvie@gmail.com

585-301-7700

.

(C) 2023 M2 COMMUNICATIONS, source M2 PressWIRE